Volume 22, Issue 2, 2022
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance
Pp: 97-107
Author(s): Abigail R. Bland, Nensi Shrestha, Maddie Berry, Christabel Wilson and John C. Ashton*
DOI: 10.2174/1568009622666220107152014
Published on: 08 March, 2022
Pharmacological Targeting of Ferroptosis in Cancer Treatment
Pp: 108-125
Author(s): Mehdi Rabiee Valashedi, Amirsadegh Nikoo, Nima Najafi-Ghalehlou, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Amaneh Mohammadi Roushandeh* and Mehryar Habibi Roudkenar*
DOI: 10.2174/1568009621666211202091523
Published on: 10 March, 2022
CEA-regulated Oncolytic Virus Anticancer Therapy: A Promising Strategy for Rare Solid Tumors
Pp: 126-132
Author(s): Yuqi Yang, Shuhang Wang, Peiwen Ma, Qiyu Tang, Yandong Li, Yuan Fang, Qi Zhu, Wei Tao, Yan Zha* and Ning Li*
DOI: 10.2174/1568009622666220202143852
Published on: 10 March, 2022
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells
Pp: 133-141
Author(s): Sina M. Matalqah*, Khalid Aiedeh, Nizar M. Mhaidat, Karem H. Alzoubi and Belal A. AL-Husein
DOI: 10.2174/1568009622666220126100532
Published on: 25 February, 2022
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies
Pp: 142-152
Author(s): Wei Shi, Lu Qi, Xiong-Bin You, Yu-Chi Chen, Yu-Lian Xu, Wei-Bang Yu, Mu-Yang Huang, Hong Zhao* and Jin-Jian Lu*
DOI: 10.2174/1568009622666220114151058
Published on: 14 February, 2022
Promotion of Cervical Cancer Cell Proliferation by miR-130b Expression Level Changes and Inhibition of its Apoptosis by Targeting CDKN1A Gene
Pp: 153-168
Author(s): Yanli Wang, Lei Yang, Caihong Fan, Hong Mu*, Munan Han, Tao Liu, Lili Xie and Qiang Gao
DOI: 10.2174/1568009622666220111090715
Published on: 08 March, 2022
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers
Pp: 169-179
Author(s): Haneen A. Basheer*, Lina Elsalem, Anwar Salem, Artysha Tailor, Keith Hunter and Kamyar Afarinkia
DOI: 10.2174/1568009622666211224111425
Published on: 03 March, 2022
